美国HIV感染者10年、20年及终生心血管疾病风险预测
该研究用数学模型预测美国接受治疗的HIV感染者(PLWH)与普通人群及HIV高风险未感染者的累积心血管疾病(CVD)风险。结果显示,男性PLWH的终生CVD风险为64.8%,高于普通人群的54.8%;女性PLWH与普通人群相近。
要点
- 男性PLWH终生CVD风险为64.8%,高于普通男性人群的54.8%。
- 60岁时男性PLWH累积CVD发病率为20.5%,高于普通人群的12.8%。
- CVD风险评估应纳入PLWH的治疗评价,预防策略可能带来健康获益。
核心结论
- 男性PLWH的终生CVD风险高于美国普通男性人群,女性PLWH与普通女性人群相似。
- CVD风险应作为PLWH治疗评价的一部分,预防策略值得评估。
研究设计与样本
- 研究采用数学模型预测累积CVD发病率。
- 模拟了美国普通人群、HIV高风险的未感染者以及PLWH三个群体的男性和女性队列。
- 模型纳入了HIV感染者和HIV高风险未感染者的较高吸烟率及吸烟所致CVD风险,并纳入独立于吸烟的HIV相关CVD风险。
主要发现
- 男性预期寿命范围为70.2至77.5年,女性为67.0至81.1年(PLWH至美国普通人群)。
- 未接受抗逆转录病毒治疗时,HIV感染男性和女性的终生CVD风险分别为12.9%和9.0%。
- 男性60岁时累积CVD发病率估计为:接受治疗的PLWH 20.5%,HIV高风险未感染者14.6%,美国普通人群12.8%。
- 女性60岁时累积CVD发病率预测为:接受治疗的PLWH 13.8%,HIV高风险未感染者9.7%,美国普通人群9.4%。
- 男性PLWH终生CVD风险为64.8%,美国普通男性人群为54.8%;女性间相似。
临床怎么用
- 在PLWH的治疗评价中应纳入CVD风险评估。
- CVD预防策略可能为PLWH带来重要健康获益,应予以评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular disease (CVD) is an increasing cause of morbidity among persons living with human immunodeficiency virus (HIV; PLWH). We projected cumulative CVD risk in PLWH in care compared to the US general population and persons HIV-uninfected, but at high risk for HIV. METHODS: We used a mathematical model to project cumulative CVD incidence. We simulated a male and female cohort for each of 3 populations: US general population; HIV-uninfected, at high risk for HIV; and PLWH. We incorporated the higher smoking prevalence and increased CVD risk due to smoking into the HIV-infected and HIV-uninfected, at high risk for HIV populations. We incorporated HIV-attributable CVD risk, independent of smoking. RESULTS: For men, life expectancy ranged from 70.2 to 77.5 years and for women from 67.0 to 81.1 years (PLWH, US general population). Without antiretroviral therapy, lifetime CVD risk for HIV-infected males and females was 12.9% and 9.0%. For males, by age 60, cumulative CVD incidence was estimated at 20.5% in PLWH in care, 14.6% in HIV-uninfected high-risk persons, and 12.8% in the US general population. For females, cumulative CVD incidence was projected to be 13.8% in PLWH in care, 9.7% for high-risk HIV-uninfected persons, and 9.4% in the US general population. Lifetime CVD risk was 64.8% for HIV-infected males compared to 54.8% for males in the US general population, but similar among females. CONCLUSIONS: CVD risks should be a part of treatment evaluation among PLWH. CVD prevention strategies could offer important health benefits for PLWH and should be evaluated.
引用
- Losina E, Hyle EP, Borre ED, et al. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2017. PMID: 28605504. doi:10.1093/cid/cix547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。